Clinical Trial: Phase 1b/2a, Where Patients Are Chosen Randomly to Test the Safety of SNIPR001 and to Assess How Well the Study Drug is Tolerated, How it is Absorbed in the Body and Its Initial Effectiveness in Patients With Certain Types of Blood Cancer

U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06938867) titled 'Phase 1b/2a, Where Patients Are Chosen Randomly to Test the Safety of SNIPR001 and to Assess How Well the Study Drug is Tolerated, How it is Absorbed in the Body and Its Initial Effectiveness in Patients With Certain Types of Blood Cancer' on April 04.

Brief Summary: This is a Phase 1b/2a study in allogenic hematopoetic stem cell transplant patients to investigate the safety, PK, PD and preliminary efficacy of multiple oral administrations of SNIPR001 when given concomitantly with SoC levofloxacin.

Study Start Date: Feb. 25

Study Type: INTERVENTIONAL

Condition: E Coli Infections

Intervention: BIOLOGICAL: SNIPR001 is a live bi...